Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta 1C Integrin expression in human endometrial proliferative diseases.

Mariarosaria Lovecchio1, Eugenio Maiorano, Rosa A Vacca

  • 1Institute of Biomembranes and Bioenergetics, National Research Council, Bari.

The American Journal of Pathology
|November 25, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Cazzato et al. Skin Mycetoma in an 11-Year-Old African Boy: Case Presentation with Emphasis on Histopathological Features and Differential Diagnosis. <i>Dermatopathology</i> 2021, <i>8</i>, 509-514.

Dermatopathology (Basel, Switzerland)·2026
Same author

Chorus line in oral squamous cell carcinoma: How stromal and immune players orchestrate tumor progression (Review).

International journal of molecular medicine·2026
Same author

Oral Undifferentiated Pleomorphic Sarcoma: A Novel <i>SPECC1L::TERT</i> Gene Fusion and a Comprehensive Literature Review.

Genes·2025
Same author

Peri-Implant Oral Squamous Cell Carcinoma (OSCC): Clinicopathological Features and Staging Issues.

Cancers·2025
Same author

Mucoepidermoid Carcinoma of the Minor Salivary Glands Diagnosed by High-Definition Ultrasound and Fine-Needle Aspiration: A Milan System-Based Retrospective Study.

Diagnostics (Basel, Switzerland)·2025
Same author

Perineuriomatous Nevus: A New Case Presentation With a Brief Review of the Literature.

The American Journal of dermatopathology·2025

Beta 1C integrin, a cell adhesion molecule, is down-regulated in endometrial adenocarcinoma but up-regulated in endometrial hyperplasia. This suggests its role in regulating endometrial cell growth and disease pathogenesis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Integrins are cell adhesion molecules crucial for tissue structure.
  • Beta 1C integrin, a variant of beta 1A integrin, inhibits epithelial cell proliferation.
  • Beta 1C integrin is downregulated in prostate cancer, suggesting a tumor-suppressive role.

Purpose of the Study:

  • To investigate beta 1C integrin expression in endometrial adenocarcinoma and hyperplasia.
  • To compare beta 1C integrin levels in cancerous, hyperplastic, and normal endometrial tissues.
  • To elucidate the role of beta 1C integrin in endometrial proliferative diseases.

Main Methods:

  • Examined beta 1C integrin at mRNA and protein levels.
  • Utilized Northern blotting, Western blotting, and immunohistochemistry.

Related Experiment Videos

  • Compared expression patterns in endometrial adenocarcinoma, hyperplasia, and normal endometria.

    • Main Results:

    • Beta 1C integrin expression was inhibited at both mRNA and protein levels in endometrial adenocarcinoma.
    • Significantly up-regulated beta 1C mRNA expression was observed in endometrial hyperplasia compared to normal endometria.
    • Beta 1C integrin expression patterns differed significantly between normal, hyperplastic, and cancerous endometrial tissues.

    Conclusions:

    • Beta 1C integrin expression is dysregulated in endometrial proliferative diseases.
    • Inhibited beta 1C integrin in adenocarcinoma suggests a potential tumor suppressor function.
    • Up-regulated beta 1C integrin in hyperplasia may indicate a role in proliferative processes, warranting further investigation into its downstream signaling.